These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11388428)

  • 1. Pseudoginsenoside-F11 attenuates morphine-induced signalling in Chinese hamster ovary-mu cells.
    Li Z; Xu NJ; Wu CF; Xiong Y; Fan HP; Zhang WB; Sun Y; Pei G
    Neuroreport; 2001 May; 12(7):1453-6. PubMed ID: 11388428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes: comparison with transfected CHO cells.
    Gray RE; Munks MW; Haynes RR; Olsen GD
    Brain Res Bull; 2001 Mar; 54(5):499-505. PubMed ID: 11397539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence.
    Wang D; Raehal KM; Bilsky EJ; Sadée W
    J Neurochem; 2001 Jun; 77(6):1590-600. PubMed ID: 11413242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
    Liu JG; Prather PL
    Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of spinal mu-opioid receptor function to activate G-protein by chronic naloxone treatment.
    Narita M; Mizoguchi H; Nagase H; Suzuki T; Tseng LF
    Brain Res; 2001 Sep; 913(2):170-3. PubMed ID: 11549382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors.
    Olianas MC; Concas D; Onali P
    Br J Pharmacol; 2006 Feb; 147(4):360-70. PubMed ID: 16402046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence.
    Xu H; Partilla JS; Wang X; Rutherford JM; Tidgewell K; Prisinzano TE; Bohn LM; Rothman RB
    Synapse; 2007 Mar; 61(3):166-75. PubMed ID: 17152090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleoside diphosphate kinase associated with membranes modulates mu-opioid receptor-mediated [35S]GTPgammaS binding and agonist binding to mu-opioid receptor.
    Zhang D; Li JG; Chen C; Liu-Chen LY
    Eur J Pharmacol; 1999 Jul; 377(2-3):223-31. PubMed ID: 10456435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of miR-139-5p on chronic morphine-induced, naloxone-precipitated cAMP overshoot in vitro.
    Cao DN; Shi JJ; Wu N; Li J
    Metab Brain Dis; 2018 Oct; 33(5):1501-1508. PubMed ID: 29916183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
    Xu H; Wang X; Wang J; Rothman RB
    Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatment.
    Selley DE; Nestler EJ; Breivogel CS; Childers SR
    Brain Res; 1997 Jan; 746(1-2):10-8. PubMed ID: 9037478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
    Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic opioid exposure on guinea pig mu opioid receptor in Chinese hamster ovary cells: comparison with human and rat receptor.
    Wallisch M; Nelson CS; Mulvaney JM; Hernandez HS; Smith SA; Olsen GD
    Biochem Pharmacol; 2007 Jun; 73(11):1818-28. PubMed ID: 17343833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens.
    Fu K; Lin H; Miyamoto Y; Wu C; Yang J; Uno K; Nitta A
    Psychopharmacology (Berl); 2016 Mar; 233(5):831-40. PubMed ID: 26621348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.
    Yabaluri N; Medzihradsky F
    Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of the involvement of mu1-opioid receptor subtype on motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouse.
    Narita M; Ozaki S; Ioka M; Mizoguchi H; Nagase H; Tseng LF; Suzuki T
    Neurosci Lett; 2001 Jul; 308(1):17-20. PubMed ID: 11445275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-mu opioid antiserum against the third external loop of the cloned mu-opioid receptor acts as a mu receptor neutral antagonist.
    Guarna M; Bartolini A; Ghelardini C; Galeotti N; Bracci L; Stefano GB; Bianchi E
    Brain Res Mol Brain Res; 2003 Nov; 119(1):100-10. PubMed ID: 14597234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of G-proteins in the mouse pons/medulla by beta-endorphin is mediated by the stimulation of mu- and putative epsilon-receptors.
    Mizoguchi H; Narita M; Nagase H; Tseng LF
    Life Sci; 2000 Oct; 67(22):2733-43. PubMed ID: 11105989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
    Lester PA; Traynor JR
    Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.